LITTLE ROCK, AR – 31 Jul, 2017 – Pharmacology University is an international educational institution which inspires education as a catalyst of the development in the progress of Medical Cannabis. Our primary function in the State of Arkansas is to educate the general public & professionals about the recently approved Arkansas Medical Marijuana Amendment known as Issue 6.
As part of our educational mission, we will offer a seminar aimed at pharmacists, lawyers, & the general public to promote the use of this medical alternative in a safe & legal manner while ensuring high quality standards. These seminars will count as continuing education credits for lawyers. In regard to the legal field, certification credits are available for Board Certified Lawyers & Legal Professionals. The Arkansas State Bar has approved six & a half (6.5) credits in CLE continuing education credits.
“After successful Medical Cannabis courses in Texas, Florida, and Puerto Rico, we are very excited about bringing our educational programs to the state of Arkansas,” as stated by Henry Levinski, National Director of Operations at Pharmacology University.
According to the Arkansas Medical Amendment, the qualifying conditions for Medical Cannabis are as follows:
Cancer Glaucoma HIV/AIDS Hepatitis C ALS Tourette’s Syndrome Alzheimer’s Disease Crohn’s Disease Ulcerative Colitis PTSD Severe Arthritis Fibromyalgia Peripheral Neuropathy Intractable pain Severe Nausea Seizures
The full health plan of cannabis includes the sixteen serious diseases listed above. Currently, there are 1,004,782 people suffering in the State of Arkansas from just six of these sixteen diseases, or 35% of the total population. If we use the national average for a patient of Medical Cannabis in the United States, which spends $388 a month for 12 months of the year, & multiply that by one million people, medicinal revenues would be a little more than $4.6 billion annually.